Royal Bank of Canada’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-131
| Closed | -$3K | – | 7352 |
|
2023
Q2 | $3K | Buy |
+131
| New | +$3K | ﹤0.01% | 6364 |
|
2022
Q4 | – | Sell |
-1,400
| Closed | -$9K | – | 7441 |
|
2022
Q3 | $9K | Buy |
1,400
+15
| +1% | +$96 | ﹤0.01% | 6012 |
|
2022
Q2 | $15K | Sell |
1,385
-125
| -8% | -$1.35K | ﹤0.01% | 5765 |
|
2022
Q1 | $28K | Sell |
1,510
-147
| -9% | -$2.73K | ﹤0.01% | 5949 |
|
2021
Q4 | $60K | Buy |
1,657
+1,497
| +936% | +$54.2K | ﹤0.01% | 5735 |
|
2021
Q3 | $12K | Buy |
160
+107
| +202% | +$8.03K | ﹤0.01% | 6392 |
|
2021
Q2 | $7K | Sell |
53
-41
| -44% | -$5.42K | ﹤0.01% | 6496 |
|
2021
Q1 | $27K | Buy |
+94
| New | +$27K | ﹤0.01% | 5769 |
|